Friday, 16 April 2010

Biogen Races to Create Test for Brain Disease Linked to MS Drug

From Bloomberg Businessweek:

April 9 (Bloomberg) -- Biogen Idec Inc. wants to take the fear out of prescribing its multiple sclerosis treatment Tysabri with a test that can tell patients their odds of getting a deadly brain illness from the drug.